Literature DB >> 17407327

Crystal structures of human carboxylesterase 1 in covalent complexes with the chemical warfare agents soman and tabun.

Christopher D Fleming1, Carol C Edwards, Stephen D Kirby, Donald M Maxwell, Philip M Potter, Douglas M Cerasoli, Matthew R Redinbo.   

Abstract

The organophosphorus nerve agents sarin, soman, tabun, and VX exert their toxic effects by inhibiting the action of human acetylcholinesterase, a member of the serine hydrolase superfamily of enzymes. The current treatments for nerve agent exposure must be administered quickly to be effective, and they often do not eliminate long-term toxic side effects associated with organophosphate poisoning. Thus, there is significant need for effective prophylactic methods to protect at-risk personnel from nerve agent exposure, and protein-based approaches have emerged as promising candidates. We present the 2.7 A resolution crystal structures of the serine hydrolase human carboxylesterase 1 (hCE1), a broad-spectrum drug metabolism enzyme, in covalent acyl-enzyme intermediate complexes with the chemical weapons soman and tabun. The structures reveal that hCE1 binds stereoselectively to these nerve agents; for example, hCE1 appears to react preferentially with the 10(4)-fold more lethal PS stereoisomer of soman relative to the PR form. In addition, structural features of the hCE1 active site indicate that the enzyme may be resistant to dead-end organophosphate aging reactions that permanently inactivate other serine hydrolases. Taken together, these data provide important structural details toward the goal of engineering hCE1 into an organophosphate hydrolase and protein-based therapeutic for nerve agent exposure.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17407327      PMCID: PMC2517171          DOI: 10.1021/bi700246n

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  48 in total

1.  The stoichiometry of protection against soman and VX toxicity in monkeys pretreated with human butyrylcholinesterase.

Authors:  L Raveh; E Grauer; J Grunwald; E Cohen; Y Ashani
Journal:  Toxicol Appl Pharmacol       Date:  1997-07       Impact factor: 4.219

2.  CASTp: Computed Atlas of Surface Topography of proteins.

Authors:  T Andrew Binkowski; Shapor Naghibzadeh; Jie Liang
Journal:  Nucleic Acids Res       Date:  2003-07-01       Impact factor: 16.971

Review 3.  Therapy for nerve agent poisoning.

Authors:  Jonathan Newmark
Journal:  Arch Neurol       Date:  2004-05

Review 4.  Organophosphates/nerve agent poisoning: mechanism of action, diagnosis, prophylaxis, and treatment.

Authors:  Jirí Bajgar
Journal:  Adv Clin Chem       Date:  2004       Impact factor: 5.394

5.  Structural and mutational studies of organophosphorus hydrolase reveal a cryptic and functional allosteric-binding site.

Authors:  Janet K Grimsley; Barbara Calamini; James R Wild; Andrew D Mesecar
Journal:  Arch Biochem Biophys       Date:  2005-09-06       Impact factor: 4.013

6.  Structural insights into drug processing by human carboxylesterase 1: tamoxifen, mevastatin, and inhibition by benzil.

Authors:  Christopher D Fleming; Sompop Bencharit; Carol C Edwards; Janice L Hyatt; Lyudmila Tsurkan; Feng Bai; Charles Fraga; Christopher L Morton; Escher L Howard-Williams; Philip M Potter; Matthew R Redinbo
Journal:  J Mol Biol       Date:  2005-09-09       Impact factor: 5.469

7.  The role of AChE active site gorge in determining stereoselectivity of charged and noncharged VX enantiomers.

Authors:  Arie Ordentlich; Dov Barak; Gali Sod-Moriah; Dana Kaplan; Dana Mizrahi; Yoffi Segall; Chanoch Kronman; Yishai Karton; Arie Lazar; Dino Marcus; Baruch Velan; Avigdor Shafferman
Journal:  Chem Biol Interact       Date:  2005-11-10       Impact factor: 5.192

8.  In vitro and in vivo characterization of recombinant human butyrylcholinesterase (Protexia) as a potential nerve agent bioscavenger.

Authors:  D M Cerasoli; E M Griffiths; B P Doctor; A Saxena; J M Fedorko; N H Greig; Q S Yu; Y Huang; H Wilgus; C N Karatzas; I Koplovitz; D E Lenz
Journal:  Chem Biol Interact       Date:  2005-12-15       Impact factor: 5.192

9.  Carboxylesterase: specificity and spontaneous reactivation of an endogenous scavenger for organophosphorus compounds.

Authors:  D M Maxwell; K M Brecht
Journal:  J Appl Toxicol       Date:  2001-12       Impact factor: 3.446

10.  Design and expression of organophosphorus acid anhydride hydrolase activity in human butyrylcholinesterase.

Authors:  C B Millard; O Lockridge; C A Broomfield
Journal:  Biochemistry       Date:  1995-12-12       Impact factor: 3.162

View more
  24 in total

1.  Glycoengineering of Esterase Activity through Metabolic Flux-Based Modulation of Sialic Acid.

Authors:  Mohit P Mathew; Elaine Tan; Jason W Labonte; Shivam Shah; Christopher T Saeui; Lingshu Liu; Rahul Bhattacharya; Patawut Bovonratwet; Jeffrey J Gray; Kevin J Yarema
Journal:  Chembiochem       Date:  2017-04-20       Impact factor: 3.164

2.  Structure of recombinant human carboxylesterase 1 isolated from whole cabbage looper larvae.

Authors:  Harry M Greenblatt; Tamara C Otto; Melanie G Kirkpatrick; Elena Kovaleva; Susan Brown; George Buchman; Douglas M Cerasoli; Joel L Sussman
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2012-02-15

Review 3.  Carboxylesterases: General detoxifying enzymes.

Authors:  M Jason Hatfield; Robyn A Umans; Janice L Hyatt; Carol C Edwards; Monika Wierdl; Lyudmila Tsurkan; Michael R Taylor; Philip M Potter
Journal:  Chem Biol Interact       Date:  2016-02-15       Impact factor: 5.192

4.  Computational Modeling of Human Paraoxonase 1: Preparation of Protein Models, Binding Studies, and Mechanistic Insights.

Authors:  Toby T Sanan; Sivaramakrishnan Muthukrishnan; Jeremy M Beck; Peng Tao; Carrigan J Hayes; Tamara C Otto; Douglas M Cerasoli; David E Lenz; Christopher M Hadad
Journal:  J Phys Org Chem       Date:  2010-04-01       Impact factor: 2.391

Review 5.  Butyrylcholinesterase for protection from organophosphorus poisons: catalytic complexities and hysteretic behavior.

Authors:  Patrick Masson; Oksana Lockridge
Journal:  Arch Biochem Biophys       Date:  2009-12-11       Impact factor: 4.013

6.  Human carboxylesterase 1 stereoselectively binds the nerve agent cyclosarin and spontaneously hydrolyzes the nerve agent sarin.

Authors:  Andrew C Hemmert; Tamara C Otto; Monika Wierdl; Carol C Edwards; Christopher D Fleming; Mary MacDonald; John R Cashman; Philip M Potter; Douglas M Cerasoli; Matthew R Redinbo
Journal:  Mol Pharmacol       Date:  2010-01-05       Impact factor: 4.436

7.  Crystal structures of brain group-VIII phospholipase A2 in nonaged complexes with the organophosphorus nerve agents soman and sarin.

Authors:  Todd M Epstein; Uttamkumar Samanta; Stephen D Kirby; Douglas M Cerasoli; Brian J Bahnson
Journal:  Biochemistry       Date:  2009-04-21       Impact factor: 3.162

8.  Covalent binding of the organophosphorus agent FP-biotin to tyrosine in eight proteins that have no active site serine.

Authors:  Hasmik Grigoryan; Bin Li; Erica K Anderson; Weihua Xue; Florian Nachon; Oksana Lockridge; Lawrence M Schopfer
Journal:  Chem Biol Interact       Date:  2009-04-02       Impact factor: 5.192

9.  Crystal structures of human group-VIIA phospholipase A2 inhibited by organophosphorus nerve agents exhibit non-aged complexes.

Authors:  Uttamkumar Samanta; Stephen D Kirby; Prabhavathi Srinivasan; Douglas M Cerasoli; Brian J Bahnson
Journal:  Biochem Pharmacol       Date:  2009-04-24       Impact factor: 5.858

10.  Structure and function of an insect α-carboxylesterase (αEsterase7) associated with insecticide resistance.

Authors:  Colin J Jackson; Jian-Wei Liu; Paul D Carr; Faisal Younus; Chris Coppin; Tamara Meirelles; Mathilde Lethier; Gunjan Pandey; David L Ollis; Robyn J Russell; Martin Weik; John G Oakeshott
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.